Literature DB >> 24067880

Activated wnt signaling in stroma contributes to development of pancreatic mucinous cystic neoplasms.

Makoto Sano1, David R Driscoll2, Wilfredo E De Jesus-Monge2, David S Klimstra3, Brian C Lewis4.   

Abstract

BACKGROUND & AIMS: Pancreatic mucinous cystic neoplasm (MCN), a cystic tumor of the pancreas that develops most frequently in women, is a potential precursor to pancreatic ductal adenocarcinoma. MCNs develop primarily in the body and tail of the pancreas and are characterized by the presence of a mucinous epithelium and ovarian-like subepithelial stroma. We investigated the involvement of Wnt signaling in KRAS-mediated pancreatic tumorigenesis and development of MCN in mice, and Wnt activation in human MCN samples.
METHODS: LSL-Kras(G12D), Ptf1a-cre mice were crossed with elastase-tva mice to allow for introduction of genes encoded by the replication-competent avian sarcoma-leukosis virus long-terminal repeat with splice acceptor viruses to pancreatic acinar cells and acinar cell progenitors, postnatally and sporadically. Repeat with splice acceptor viruses that expressed Wnt1 were delivered to the pancreatic epithelium of these mice; pancreatic lesions were analyzed by histopathology and immunohistochemical analyses. We analyzed levels of factors in Wnt signaling pathways in 19 MCN samples from patients.
RESULTS: Expression of Wnt1 in the pancreatic acinar cells and acinar cell progenitors of female mice led to development of unilocular or multilocular epithelial cysts in the pancreas body and tail, similar to MCN. The cystic lesions resembled the estrogen receptor- and progesterone receptor-positive ovarian-like stroma of MCN, but lacked the typical mucinous epithelium. Activated Wnt signaling, based on nuclear localization of β-catenin, was detected in the stroma but not cyst epithelium. Wnt signaling to β-catenin was found to be activated in MCN samples from patients, within the ovarian-like stroma, consistent with the findings in mice.
CONCLUSIONS: Based on studies of mice and pancreatic MCN samples from patients, the canonical Wnt signaling pathway becomes activated and promotes development of the ovarian-like stroma to contribute to formation of MCNs.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ER; FZD; MCN; Mouse Model; Mucinous Cystic Neoplasm (MCN); Ovarian-Like Stroma; PCP; PDAC; PR; PanIN; RCAS; Wnt Signaling Pathway; estrogen receptor; frizzled; mucinous cystic neoplasm; pancreatic ductal adenocarcinoma; pancreatic intraepithelial neoplasia; planar cell polarity; progesterone receptor; replication-competent avian sarcoma-leukosis virus long-terminal repeat with splice acceptor

Mesh:

Substances:

Year:  2013        PMID: 24067880      PMCID: PMC3919634          DOI: 10.1053/j.gastro.2013.09.044

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  47 in total

1.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

Review 2.  Towards an integrated view of Wnt signaling in development.

Authors:  Renée van Amerongen; Roel Nusse
Journal:  Development       Date:  2009-10       Impact factor: 6.868

3.  Beta-catenin is essential for pancreatic acinar but not islet development.

Authors:  L Charles Murtaugh; Anica C Law; Yuval Dor; Douglas A Melton
Journal:  Development       Date:  2005-09-28       Impact factor: 6.868

Review 4.  Cystic precursors to invasive pancreatic cancer.

Authors:  Hanno Matthaei; Richard D Schulick; Ralph H Hruban; Anirban Maitra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03       Impact factor: 46.802

5.  Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.

Authors:  Susan C Abraham; David S Klimstra; Robb E Wilentz; Charles J Yeo; Kevin Conlon; Murray Brennan; John L Cameron; Tsung-Teh Wu; Ralph H Hruban
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.

Authors:  Jian Wu; Hanno Matthaei; Anirban Maitra; Marco Dal Molin; Laura D Wood; James R Eshleman; Michael Goggins; Marcia I Canto; Richard D Schulick; Barish H Edil; Christopher L Wolfgang; Alison P Klein; Luis A Diaz; Peter J Allen; C Max Schmidt; Kenneth W Kinzler; Nickolas Papadopoulos; Ralph H Hruban; Bert Vogelstein
Journal:  Sci Transl Med       Date:  2011-07-20       Impact factor: 17.956

Review 7.  Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells.

Authors:  Minoti V Apte; Jeremy S Wilson
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

8.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

9.  Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization.

Authors:  Lidong Wang; David G Heidt; Cheong J Lee; Huibin Yang; Craig D Logsdon; Lizhi Zhang; Eric R Fearon; Mats Ljungman; Diane M Simeone
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

10.  Stabilization of beta-catenin induces pancreas tumor formation.

Authors:  Patrick W Heiser; David A Cano; Limor Landsman; Grace E Kim; James G Kench; David S Klimstra; Maketo M Taketo; Andrew V Biankin; Matthias Hebrok
Journal:  Gastroenterology       Date:  2008-07-09       Impact factor: 22.682

View more
  18 in total

Review 1.  Cells of origin of pancreatic neoplasms.

Authors:  Junpei Yamaguchi; Yukihiro Yokoyama; Toshio Kokuryo; Tomoki Ebata; Masato Nagino
Journal:  Surg Today       Date:  2017-03-04       Impact factor: 2.549

Review 2.  Insights into the Pathogenesis of Pancreatic Cystic Neoplasms.

Authors:  Vrishketan Sethi; Bhuwan Giri; Ashok Saluja; Vikas Dudeja
Journal:  Dig Dis Sci       Date:  2017-05-12       Impact factor: 3.199

Review 3.  Approach to cystic lesions of the pancreas.

Authors:  Roland M Schmid; Jens T Siveke
Journal:  Wien Med Wochenschr       Date:  2013-11-20

Review 4.  Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets.

Authors:  Martin C Whittle; Sunil R Hingorani
Journal:  Gastroenterology       Date:  2019-02-02       Impact factor: 22.682

Review 5.  The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities.

Authors:  Yohei Masugi
Journal:  Cancers (Basel)       Date:  2022-07-05       Impact factor: 6.575

6.  Low expression of secreted frizzled-related protein 2 and nuclear accumulation of β-catenin in aggressive nonfunctioning pituitary adenoma.

Authors:  Youtu Wu; Jiwei Bai; Linchuan Hong; Chunhui Liu; Shengyuan Yu; Guoqiang Yu; Yazhuo Zhang
Journal:  Oncol Lett       Date:  2016-05-13       Impact factor: 2.967

7.  APC haploinsufficiency coupled with p53 loss sufficiently induces mucinous cystic neoplasms and invasive pancreatic carcinoma in mice.

Authors:  T-L Kuo; C-C Weng; K-K Kuo; C-Y Chen; D-C Wu; W-C Hung; K-H Cheng
Journal:  Oncogene       Date:  2015-09-28       Impact factor: 9.867

Review 8.  Regulation of Cellular Identity in Cancer.

Authors:  Nilotpal Roy; Matthias Hebrok
Journal:  Dev Cell       Date:  2015-12-21       Impact factor: 12.270

9.  Inhibition of β-Catenin Activity Abolishes LKB1 Loss-Driven Pancreatic Cystadenoma in Mice.

Authors:  Mei-Jen Hsieh; Ching-Chieh Weng; Yu-Chun Lin; Chia-Chen Wu; Li-Tzong Chen; Kuang-Hung Cheng
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 10.  Utilizing past and present mouse systems to engineer more relevant pancreatic cancer models.

Authors:  Brian T DeCant; Daniel R Principe; Carmen Guerra; Marina Pasca di Magliano; Paul J Grippo
Journal:  Front Physiol       Date:  2014-12-04       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.